Bio-Rad Laboratories Class A
435 hedge funds and large institutions have $4.71B invested in Bio-Rad Laboratories Class A in 2025 Q1 according to their latest regulatory filings, with 67 funds opening new positions, 137 increasing their positions, 166 reducing their positions, and 83 closing their positions.
2.94% more ownership
Funds ownership: 81.97% → 84.91% (+2.9%)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
4% less call options, than puts
Call options by funds: $3.6M | Put options by funds: $3.77M
5% less funds holding
Funds holding: 456 → 435 (-21)
17% less repeat investments, than reductions
Existing positions increased: 137 | Existing positions reduced: 166
19% less first-time investments, than exits
New positions opened: 67 | Existing positions closed: 83
24% less capital invested
Capital invested by funds: $6.17B → $4.71B (-$1.46B)
Top Buyers
| 1 |
First Eagle Investment Management
New York
|
+$257M |
| 2 |
FPA
First Pacific Advisors
El Segundo,
California
|
+$64.6M |
| 3 |
AI
Ariel Investments
Chicago,
Illinois
|
+$49.4M |
| 4 |
HP
Hound Partners
New York
|
+$43M |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$41.6M |
Top Sellers
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$64M |
| 2 |
Select Equity Group
New York
|
-$58.8M |
| 3 |
Westfield Capital Management
Boston,
Massachusetts
|
-$39.1M |
| 4 |
VanEck Associates
New York
|
-$38.1M |
| 5 |
WCM
Wedge Capital Management
Charlotte,
North Carolina
|
-$28.7M |
BIO Hedge Fund Activity: Q1 2025 in Review
435 of the 7,457 institutional investors tracked by Wall St. Rank reported a position in Bio-Rad Laboratories Class A (BIO) for Q1 2025, worth a combined $4.71B — down 24% from $6.17B a quarter earlier.
Sellers outnumbered buyers: 83 funds closed out of BIO and 67 opened new positions — a net loss of 16 holders — while 166 trimmed existing stakes and 137 added.
The largest buyer was First Eagle Investment Management, adding an estimated $257M. The largest seller was Point72 Asset Management, cutting an estimated $64M.
- 435 institutional investors held Bio-Rad Laboratories Class A (BIO) as of Q1 2025, down from 456 in Q4 2024.
- Funds reported $4.71B of Bio-Rad Laboratories Class A stock for Q1 2025, down 24% quarter-over-quarter.
- 67 funds opened new Bio-Rad Laboratories Class A positions in Q1 2025 and 83 closed out, a net change of -16 holders.
- The largest Bio-Rad Laboratories Class A buyer in Q1 2025 was First Eagle Investment Management, an estimated $257M added.
- The largest Bio-Rad Laboratories Class A seller in Q1 2025 was Point72 Asset Management, an estimated $64M sold.
Based on aggregated 13F filings for Q1 2025.